Specific induction of pulmonary indoleamine 2,3-dioxygenase by bacterial lipopolysaccharide - PubMed (original) (raw)
Specific induction of pulmonary indoleamine 2,3-dioxygenase by bacterial lipopolysaccharide
O Hayaishi et al. Ciba Found Symp. 1978 Jun.
Abstract
Indoleamine 2,3-dioxygenase (molecular weight about 42,000) has been purified from rabbit intestines and contains one mole of protohaem IX as the sole prosthetic group. It catalyses the oxidative cleavage of the pyrrole ring of various indoleamines with a much broader specificity of substrate than tryptophan 2,3-dioxygenase. The enzyme has an absolute requirement for superoxide anion for catalytic activity. The enzyme was induced specifically in the lungs of mice for 24 h after administration of the lipopolysaccharide fraction of E. coli. This increase is due to synthesis of enzyme protein and is specific for the lipopolysaccharide fraction. These results are interpreted to mean that indoleamine dioxygenase is induced in pulmonary inflammatory processes in response to an increase in production of superoxide anion, 5-hydroxytryptamine or other indoleamines in the lung as a consequence of inflammation. The dioxygenase reaction is a more innocuous way of disposing of superoxide than dismutation.
Similar articles
- Specific induction of indoleamine 2,3-dioxygenase by bacterial lipopolysaccharide in the mouse lung.
Yoshida R, Urade Y, Nakata K, Watanabe Y, Hayaishi O. Yoshida R, et al. Arch Biochem Biophys. 1981 Dec;212(2):629-37. doi: 10.1016/0003-9861(81)90406-9. Arch Biochem Biophys. 1981. PMID: 6976775 No abstract available. - Interferon: a mediator of indoleamine 2,3-dioxygenase induction by lipopolysaccharide, poly(I) X poly(C), and pokeweed mitogen in mouse lung.
Yoshida R, Oku T, Imanishi J, Kishida T, Hayaishi O. Yoshida R, et al. Arch Biochem Biophys. 1986 Sep;249(2):596-604. doi: 10.1016/0003-9861(86)90038-x. Arch Biochem Biophys. 1986. PMID: 3489442 - Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide.
Yoshida R, Hayaishi O. Yoshida R, et al. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3998-4000. doi: 10.1073/pnas.75.8.3998. Proc Natl Acad Sci U S A. 1978. PMID: 279015 Free PMC article. - Utilization of superoxide anion by indoleamine oxygenase-catalyzed tryptophan and indoleamine oxidation.
Hayaishi O. Hayaishi O. Adv Exp Med Biol. 1996;398:285-9. doi: 10.1007/978-1-4613-0381-7_45. Adv Exp Med Biol. 1996. PMID: 8906279 Review. - [Rhythms and physiological significance of indoleamine 2,3-dioxygenase (author's transl)].
Yoshida R, Hayaishi O. Yoshida R, et al. Tanpakushitsu Kakusan Koso. 1982 Jan 5;27(2):143-51. Tanpakushitsu Kakusan Koso. 1982. PMID: 6175995 Review. Japanese. No abstract available.
Cited by
- Kynurenine pathway metabolites in humans: disease and healthy States.
Chen Y, Guillemin GJ. Chen Y, et al. Int J Tryptophan Res. 2009;2:1-19. doi: 10.4137/ijtr.s2097. Epub 2009 Jan 8. Int J Tryptophan Res. 2009. PMID: 22084578 Free PMC article. - Neurological and Inflammatory Manifestations in Sjögren's Syndrome: The Role of the Kynurenine Metabolic Pathway.
de Oliveira FR, Fantucci MZ, Adriano L, Valim V, Cunha TM, Louzada-Junior P, Rocha EM. de Oliveira FR, et al. Int J Mol Sci. 2018 Dec 8;19(12):3953. doi: 10.3390/ijms19123953. Int J Mol Sci. 2018. PMID: 30544839 Free PMC article. Review. - Low Serum Tryptophan Levels as an Indicator of Global Cognitive Performance in Nondemented Women over 50 Years of Age.
Ramos-Chávez LA, Roldán-Roldán G, García-Juárez B, González-Esquivel D, Pérez de la Cruz G, Pineda B, Ramírez-Ortega D, García Muñoz I, Jiménez Herrera B, Ríos C, Gómez-Manzo S, Marcial-Quino J, Sánchez Chapul L, Carrillo Mora P, Pérez de la Cruz V. Ramos-Chávez LA, et al. Oxid Med Cell Longev. 2018 Nov 21;2018:8604718. doi: 10.1155/2018/8604718. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30584466 Free PMC article. - Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences.
Davar D, Bahary N. Davar D, et al. Target Oncol. 2018 Apr;13(2):125-140. doi: 10.1007/s11523-017-0547-9. Target Oncol. 2018. PMID: 29302770 Review. - Induction of indoleamine-2,3 dioxygenase in bone marrow stromal cells inhibits myeloma cell growth.
Pfeifer S, Schreder M, Bolomsky A, Graffi S, Fuchs D, Sahota SS, Ludwig H, Zojer N. Pfeifer S, et al. J Cancer Res Clin Oncol. 2012 Nov;138(11):1821-30. doi: 10.1007/s00432-012-1259-2. Epub 2012 Jun 22. J Cancer Res Clin Oncol. 2012. PMID: 22722711